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1) To develop a machine learning approach for detecting stroke cases and subtypes from
hospitalization data, 2) to assess algorithm performance and predictors on real-world data
collected by a large-scale epidemiology study in the US; and 3) to identify directions for
future development of high-precision stroke phenotypic signatures.
Materials and methods
We utilized 8,131 hospitalization events (ICD-9 codes 430–438) collected from the Greater
Cincinnati/Northern Kentucky Stroke Study in 2005 and 2010. Detailed information from
patients’ medical records was abstracted for each event by trained research nurses. By ana-
lyzing the broad list of demographic and clinical variables, the machine learning algorithms
predicted whether an event was a stroke case and, if so, the stroke subtype. The perfor-
mance was validated on gold-standard labels adjudicated by stroke physicians, and results
were compared with stroke classifications based on ICD-9 discharge codes, as well as
labels determined by study nurses.
Results
The best performing machine learning algorithm achieved a performance of 88.57%/
93.81%/92.80%/93.30%/89.84%/98.01% (accuracy/precision/recall/F-measure/area under
ROC curve/area under precision-recall curve) on stroke case detection. For detecting stroke
subtypes, the algorithm yielded an overall accuracy of 87.39% and greater than 85% preci-
sion on individual subtypes. The machine learning algorithms significantly outperformed the
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ICD-9 method on all measures (P value<0.001). Their performance was comparable to that
of study nurses, with better tradeoff between precision and recall. The feature selection
uncovered a subset of predictive variables that could facilitate future development of effec-
tive stroke phenotyping algorithms.
Discussion and conclusions
By analyzing a broad array of patient data, the machine learning technologies held promise
for improving detection of stroke diagnosis, thus unlocking high statistical power for subse-
quent genetic and genomic studies.
Introduction
Stroke is the fifth leading cause of death in the US and is a major cause of adult disability.[1]
Patients with stroke require expensive long-term rehabilitation care, resulting in an annual
cost of over $33 billion nationally.[1] The main pathological subtypes of stroke include ische-
mic stroke, hemorrhagic stroke, and transient ischemic attack (TIA). Understanding clinical
causation of stroke and its subtypes is critical for the planning, implementation, and evaluation
of patient treatments. In particular, it will enable development of stroke phenotypes, which is
the first step toward more powerful genetic and genomic studies that can lead to a better
understanding of stroke etiology.[2–4] However, determination of stroke and its subtypes
requires integration of multiple demographic, clinical, diagnostic, and imaging features; conse-
quently, there is great variability between individual patients.[5–12]
Previous efforts have been made to identify predictors associated with stroke diagnosis.
Medical history of hypertension, hyperlipidemia, obesity, diabetes mellitus, and atrial fibrilla-
tion have been commonly recognized as risk factors associated with stroke.[6, 9, 13–16] Com-
puted tomography (CT) and magnetic resonance imaging (MRI) are routinely used in the
diagnostic work-up of stroke patients. As new technologies of image processing have been
introduced over time, imaging patterns have been increasingly adopted as “image markers” to
facilitate stroke diagnosis.[17–19] In addition to clinical characteristics, patient demographics,
family history, and substance use behaviors are considered influential factors on their risk of
stroke.[6, 11, 20] Despite these findings, no single factor or group of factors would make a defi-
nite diagnosis. Rule-based approaches have been developed to heuristically combine the pre-
dictors to identify stroke cases, but large variability in reported sensitivities and specificities
exists for the assessments.[21, 22] To detect stroke subtypes, current studies typically rely on
International Classification of Diseases (ICD) codes or death certificate data. However, they
are limited by precisions ranging from 6% to 97% across study designs and stroke subtypes.
[23–28] Physician review of patients’ complicated medical records remains the gold-standard
method of ascertaining stroke diagnosis, and the process is labor intensive and expensive.
[29, 30]
Machine learning (ML) is a methodology of data analytics that utilizes computerized algo-
rithms to identify the relation between, and make prediction on, sets of data. By iteratively
learning from example inputs (i.e., training data), ML algorithms identify hidden insights of
the data and generate predictions on unseen examples (i.e., test data). In the literature of stroke
research, ML technologies have been applied to identify stroke cases,[15, 31] predict stroke
outcomes (e.g., mortality and recurrent stroke),[32–34] and evaluate therapy outcomes.[35,
36] Nevertheless, most of the studies have been limited to small patient cohorts (fewer than
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200 samples), explored limited predictors, and did not have statistical power to discover rela-
tionships among a larger set of risk factors. A handful of studies utilized larger datasets (about
3000) to develop stroke detection models.[37, 38] However, their optimal accuracy plateaued
at less than 75%.[37] In particular, none of the studies investigated the detection of stroke sub-
types. Because ascertainment of stroke subtypes requires integration of findings from multiple
clinical assessments and diagnostic tests,[39–41] the complexity and accuracy in detecting
individual subtypes can vary dramatically.[25, 26] Additional study is therefore required to
evaluate the effectiveness of ML technologies on stroke subtype detection.
Epidemiology studies collect a tremendous amount of multi-site samples with correspond-
ing demographic and clinical data.[5, 42–44] In particular, some studies utilize physician
review of the electronic health record (EHR) data to confirm stroke diagnosis for improved
ascertainment accuracy.[43] By utilizing a comprehensive list of clinical data collected from
such population-based metropolitan study, we investigated ML methodology to detect stroke
diagnosis.
Objective
Our long-term objective is to develop a phenotyping algorithm that retrospectively identifies
stroke cases across institutions to support genetic and genomic research. Because genetic and
genomic studies typically require a case cohort of high purity (represented with a precision of
95%), we aim to establish a ML approach to detect stroke diagnosis with high precision and
adequate recall. The specific aims of this study are: 1) to develop a ML approach to detect
stroke cases and subtypes based on a broad array of hospitalization data; 2) to assess algorithm
performance and predictors on real-world data collected from a large-scale epidemiology
study of stroke in the US; and 3) to identify directions for future development of stroke pheno-
typic signatures. The study is the first, known to us, to investigate detection of multiple stroke
subtypes in a large-scale via ML technologies.
Materials and methods
We utilized all hospitalization events collected from the Greater Cincinnati/Northern Ken-
tucky Stroke Study (GCNKSS), a large-scale, population-based epidemiology study that mea-
sures temporal trends in stroke incidence rates in a population of 1.3 million.[43] The study
was approved by the institutional review boards of participating hospitals (University of Cin-
cinnati, Tri-Health, the Jewish Hospital and Mercy Hospital System, the Christ Hospital, and
the St. Elizabeth Healthcare) and a waiver of individual consent was authorized (Study ID:
2013–3959 04061501).
Fig 1 diagrams the overall processes of the study. We first extracted clinical variables and
stroke adjudications for all hospitalization events from the GCNKSS data (processes 1 and 2 in
Fig 1). ML technologies were then applied to build stroke detection models with three steps: 1)
features were generated from the variables and were normalized (process 3), 2) feature selec-
tion was applied to select predictive features for model construction (process 4), and 3) a vari-
ety of ML algorithms were developed to detect stroke diagnosis based on the selected features
(process 5). Finally, the performance of ML models was assessed and compared with that of
ICD-9 method and human experts (process 6).
Stroke events and patient EHR data
The GCNKSS collected and ascertained all potential stroke events that occurred among resi-
dents of the study region in 2005 and 2010. The GCNKSS first identified hospitalization events
with potential stroke-related diagnoses from all 19 regional hospitals using ICD-9-CM codes
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(primary or secondary discharge diagnoses) of 430–438 that match the World Health Organi-
zation definition of stroke.[45] Detailed information from patients’ EHRs was then abstracted
for each event by trained research nurses (process 1 in Fig 1). We selected all 316 structured
variables that specified patients’ characteristics, encounter information, physiological status,
diagnostic tests, medical histories, hospital diagnoses, interventions and clinical outcomes.
The variables were categorized into 19 sets, which are summarized in Table 1. The description
of each variable is presented in S1 Table. Because our goal was to retrospectively identify stroke
cases, we leveraged all available information from a patient’s hospitalization, including ICD
discharge codes, interventions, and clinical outcomes.
Gold-standard stroke diagnosis
Ten stroke physicians were available to adjudicate study abstracts. Each abstract was reviewed
by at least one stroke physician to determine whether the event was a stroke case and, if so, the
stroke subtype (process 2 in Fig 1). Complicated events (35.1% of the collected events) were
adjudicated by at least two physicians through group discussion to ensure the accuracy of diag-
nosis. The adjudicators had rigid criteria to determine stroke cases and subtypes,[43] but they
were allowed to use their clinical judgment to clarify events (e.g., MRI negative for stroke but
Fig 1. The overall processes of the study.
https://doi.org/10.1371/journal.pone.0192586.g001
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clinical symptoms and history consistent with stroke diagnosis could be called a case). For our
study, we maintained the case criteria without exception: an event was labeled as a stroke case
only if it met the case criteria. The event labels adjudicated by physicians were used to train
and evaluate the ML algorithms.
Detecting stroke diagnosis with ML technologies
Feature extraction. We followed the methodology used in our earlier studies to process
the clinical variables.[46–48] All nominal variables (e.g., sex, ICD-9 codes) were converted to
binary features using dummy variable coding.[49] We then used two methods to discretize
and normalize numerical variables. The National Institute of Health Stroke Scale (NIHSS) and
Glasgow Coma Scale were discretized into categories based on clinical classification.[50, 51]
For example, the NIHSS was discretized into no symptoms (0), mild (1–4), moderate (5–14),
severe (15–24), and very severe (25–42) to stratify stroke severity.[50] The real-valued vital
signs were discretized into “normal” and “out of normal range”.[52] The remaining variables,
including age and laboratory results, were normalized using z-score normalization.[53]






DEMO 6 Patient demographics, including age, sex, race, ethnicity, marital status and
employment status
SU 11 Patients’ history of substance use (smoking, alcohol and street drugs)
VI 4 Visit information at time of admission (e.g., type of first medical contact, type
of visited institution)
ED 13 Evaluations (e.g., blood pressure, Glasgow Coma Scale) performed in the
emergency department
SE 29 Stroke-related evaluations (e.g., NIH stroke scale)
SS 20 Signs and symptoms that caused a patient to seek medical attention (e.g.,
weakness, headache, speech and vision)
CT/MRI 24 CT or MRI performed (Yes/No) and, if so, the findings (e.g., normal, acute
infarct, intracerebral hemorrhage)
ANG 6 MRA, CTA, or cerebral angiography performed (Yes/No) and, if so, the
findings (e.g., normal/abnormal)
CU 2 Carotid ultrasound performed (Yes/No) and, if so, the findings (e.g., normal/
abnormal)
ECHO 19 Echocardiogram performed (Yes/No) and, if so, the findings (e.g.,
cardiomyopathy Yes/No)
EKG 16 Electrocardiogram performed (Yes/No) and, if so, the findings (e.g., normal/
abnormal)
LAB 14 Laboratory results collected during hospitalization (e.g., white blood cell count,
glucose level, total cholesterol)
MH 52 General medical history prior to hospitalization (e.g., history of hypertension
Yes/No)
SH 18 History of stroke prior to hospitalization (e.g., ischemic stroke Yes/No)
ICD9 1 Primary and secondary ICD-9 codes on patients’ discharge lists
DX 47 Complications and new diagnoses during hospitalization (e.g., pain, seizure,
cardiac arrest Yes/No)
IT 13 Interventions performed (e.g., aneurysm clipping/coiling, clot evacuation Yes/
No)
TH 15 Therapies performed (e.g., physical, occupational or speech therapy Yes/No)
OC 6 Clinical outcome of hospitalization (e.g., disposition at discharge, modified
Rankin Scale)
https://doi.org/10.1371/journal.pone.0192586.t001
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Because a patient might not take all diagnostic tests and assessments during hospitalization,
the event samples could have missing values on certain variables. To alleviate the influence of
missing data, we implemented unique-value imputation and grand mean and mode imputa-
tion based on their computational efficiency and performance in ML tasks.[54, 55] For each
nominal variable, we created a unique category representing “unknown” for missing values.
For a numerical variable, we replaced the missing values with the variable’s mean (for continu-
ous variables) or mode (for discrete variables) derived from the data.
Feature selection. The feature extraction yielded a large number of features for model
construction. To reduce noise and avoid overfitting, we implemented a wrapper-based feature
selection using logistic regression (LR) and best first search.[56, 57] The feature selection also
provided a better insight of individual variables contributing to stroke diagnosis.
In each iteration, features from a category variable (Table 1) was added to the LR for train-
ing and testing to determine the top-performing category. The process was repeated until all
19 categories were added. The optimal feature set was chosen as the point at which additional
features did not increase predictive performance. Note that some ML algorithms (e.g., random
forest) inherently eliminate irrelevant features during model training, and they might not ben-
efit from feature selection. As such, whether using the original or the optimal feature sets was
tuned for individual ML algorithms based on the cross-validation performance.
Stroke case detection. We formatted detection of stroke cases as a binary-class classifica-
tion and implemented four ML classifiers: 1) LR, a direct probability model that measures the
linear relationship between features and stroke diagnosis;[58] 2) support vector machines with
polynomial (SVM-P) and radial basis function (SVM-R) kernels, which construct hyperplanes
in linear and non-linear feature spaces to classify stroke cases and non-stroke “controls”;[59]
3) random forest (RF), which uses a multitude of decision trees to learn a highly irregular com-
bination of features;[60] and 4) artificial neural networks (ANNs) that comprise three layers of
LR models to learn non-linear patterns among features.[58] We chose these classifiers to allow
for the possibility of linear and non-linear relationships between features and stroke diagnosis.
The classifiers output predictive values (-1, +1) to represent the possibility of stroke diag-
nosis. If a predictive value was positive, we assigned +1 to the output suggesting a stroke case.
Otherwise, we assigned -1 suggesting a non-stroke “control”. Given that the values output by
ANNs ranged between 0 and 1, we set the threshold to 0.5 for ANNs.
Stroke subtype detection. We modeled stroke subtype detection as a task of four-class
(ischemic stroke, hemorrhagic stroke, TIA, and non-stroke “control”) classification. The RF
and ANNs are natural multiclass classifiers, and they can predict the possibilities of classes
simultaneously. The LR and SVM were extended to multiclass setting using the one-versus-all
approach,[58] which trained a single classifier per class, with the samples of that class as cases
and all other samples as controls. After training, it applied all classifiers to a test example and
predicted the class for which the corresponding classifier output the highest predictive value.
Coping with imbalanced data. The distribution of stroke events in the real-world data
was unbalanced, which could cause prediction bias and compromise the performance of ML
algorithms.[61] Because the majority of abstracted events were stroke cases, the ML algorithms
might predict all events as cases; this would achieve high accuracy, but would sacrifice other
measures such as precision. To address this issue, we adopted adaptive synthetic sampling
(ADA-SYN) to oversample minority class (e.g., non-stroke “control”) in the training data.[62]
The algorithm adaptively synthesized different numbers of samples from each minority exam-
ple until the classes reached similar sizes. The balanced data were then used to train the ML
algorithms. Similar to feature selection, the ADA-SYN sampling was integrated into the cross-
validation process.
Automated detection of stroke diagnosis
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Baseline systems
We implemented two baseline systems to compare with the ML algorithms (process 6 in
Fig 1). The first baseline was an ICD9-coded method (denoted by ICD9) because phenotype
algorithms frequently use ICD codes to identify qualified cases.[26, 63] The method was devel-
oped to identify high-precision stroke cohorts, and its logic is illustrated in Fig 2.[26] In the
GCNKSS the abstractors (trained research nurses) also provided their judgments of stroke
diagnosis for each event. We used these clinical judgments as the second baseline (denoted by
CLIN) that simulated the decision-making of research nurses on stroke diagnosis.
Experiments
Evaluation metrics. We adopted five customary evaluation metrics to assess algorithm
performance: 1) Accuracy = (True positives+True negatives)/Total events (denoted by ACC);
2) Precision = True positives/(True positives+False positives) (denoted by P); 3) Recall = True
positives/(True positives+False negatives) (denoted by R); 4) F-measure = 2PxR/(P+R)
(denoted by F); and 5) the area under receiver operating characteristics curves, which mea-
sures balance between recall and specificity (denoted by AUC).[64–66] Because the goal of this
study was to identify high-precision stroke cohorts with adequate recall, we also generated pre-
cision-recall curves and measured the area under the curve (denoted by AUC-PR) to assess
balance between precision and recall.[67]
Experiment setup. We performed a stratified random sampling based on number of
events for each stroke subtype to split the data into two sets, 80% for training and development
and 20% for testing and error analysis. Two iterations of ten-fold cross-validation were applied
on the training set to select features and tune model parameters. Both cross-validation pro-
cesses used the same data partition. The first cross-validation was applied to perform feature
selection and generate the optimal feature set. The second cross-validation was used to tune
hyper-parameters of the ML classifiers, including cost parameters (C) for LR, SVM-P, SVM-R
and ANN (screened at 2 increments from 2−10 to 216), optimal degree for SVM-P (screened
from 1 to 6), parameter γ for SVM-R (screened from 2−15 to 25), number of trees for RF
Fig 2. The ICD-9 coded baseline.
https://doi.org/10.1371/journal.pone.0192586.g002
Automated detection of stroke diagnosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0192586 February 14, 2018 7 / 20
(screened from 22 to 211), and number of neuros for ANNs (screened at 20 increments from
10 to 100). Whether using ADA-SYN sampling and the optimal feature set was also tuned dur-
ing the second cross-validation process. Finally, the ML classifiers with optimal parameters
were applied to the test data for performance comparison and error analysis.
For stroke case detection, events with a definite stroke diagnosis were labeled +1, and events
without a stroke diagnosis were labeled -1. The event labels were then used to train and evalu-
ate the ML algorithms. Feature selection was performed to identify predictive variables. All
evaluation metrics were used, and we adopted the AUC-PR as the primary measure.
For stroke subtype detection, events were grouped into four categories (ischemic stroke,
hemorrhagic stroke, TIA, and non-stroke “control”, Fig 3) based on their subtypes. They were
then labeled 1–4 to train and evaluate the algorithms. The optimal feature set was inherited
from stroke case detection that captured informative variables for all subtypes. We did not per-
form feature selection in the multiclass setting because the small sample sizes of minority clas-
ses (e.g., hemorrhagic stroke) could cause overfitting during feature selection and propagate
errors to the classifiers.[68, 69] For evaluation we reported overall accuracy, and precision,
recall, and F-measure on each category. We also compared confusion matrices between differ-
ent algorithms. The accuracy was adopted as the primary measure. We did not assess AUC
and AUC-PR because they were primarily designed for binary classification.
Statistical analysis. Our primary outcome was to demonstrate that using the ML
approach would detect stroke diagnosis more accurately, compared with baseline methods
Fig 3. The event distribution of stroke subtypes among the four categories.
https://doi.org/10.1371/journal.pone.0192586.g003
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(ICD9 and CLIN). To this end, the statistical significance of the difference between systems’
performances was assessed and reported using paired T-test.[70]
In our experiments the ML algorithms, evaluation metrics, and statistical analyses were
implemented using MATLAB Version 2014a.[71]
Results
Descriptive statistics of the data set
The study personnel reviewed a total of 8,131 events, of which 6,987 samples (85.9%) were
adjudicated to be stroke cases. We excluded 50 samples (0.6%) due to undetermined stroke
subtypes. Fig 3 depicts the event distribution of stroke subtypes among the four categories.
After stratified sampling and feature extraction, the training set contained 6,463 samples
(3,327/692/1,529/915 ischemic/hemorrhagic/TIA/non-stroke) with 1,071 unique features. The
test set had 1,618 samples (832/174/383/229 ischemic/hemorrhagic/TIA/non-stroke) with 994
features. In total there were 1,091 features in the data set.
Results of feature selection
Fig 4 shows the performance curves on cross-validation for each incremental variable set addi-
tion. All performance measures except recall increased and then stabilized. The best AUC-PR
and AUC achieved by feature selection were 97.04% and 86.23% respectively (dash line in Fig
4). The optimal feature set included CT/MRI findings (CT/MRI), signs and symptoms (SS),
interventions (IT), ED assessments (ED), findings from angiography (ANG) and carotid ultra-
sound (CU) tests, ICD-9 codes (ICD9), substance use characteristics (SU), and demographics
Fig 4. The performance curves when adding the variable sets (Table 1).
https://doi.org/10.1371/journal.pone.0192586.g004
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(DEMO). Using only CT/MRI and SS achieved an AUC-PR/AUC of 96.53%/84.69% (dotted
line), which was close to the optimal performance.
Performance of stroke case detection
Table 2 shows the performance of different classification algorithms on detecting stroke cases.
Compared with the ICD9 baseline, the ML classifiers performed significantly better on all
measures (Table 3). They also outperformed research nurses (CLIN) on all measures except
recall. Fig 5 plots precision-recall curves generated by the algorithms. The best curves were
generated by the RF, with AUC-PR of 97.54% on cross-validation and 98.01% on the test set.
Table 2. Performance of different classification algorithms for stroke case identification.
Measure Cross Validation Performance [%]
ICD9 CLIN LR SVM-P SVM-R RF ANN
ACC 60.45 85.41 87.17 87.56 88.07 87.56 87.35
P 87.96 86.06 88.96 90.26 90.32 92.75 91.25
R 62.47 99.05 97.11 95.87 96.45 92.81 94.31
F 73.05 92.10 92.86 92.97 93.28 92.78 92.75
AUC 55.83 50.60 86.11 85.93 86.41 88.02 85.98
AUC-PR 87.91 83.29 97.15 96.81 96.86 97.54 96.74
Measure Test Set Performance [%]
ICD9 CLIN LR SVM-P SVM-R RF ANN
ACC 61.68 85.85 87.21 87.89 88.38 88.57 86.90
P 88.41 86.39 89.40 90.94 90.99 93.81 91.59
R 63.72 99.14 96.54 95.39 95.97 92.80 93.31
F 74.06 92.32 92.84 93.11 93.41 93.30 92.44
AUC 55.40 51.65 86.69 86.31 86.61 89.84 85.87
AUC-PR 88.29 83.51 97.23 97.19 97.22 98.01 96.89
Bold numbers indicate the best results.
https://doi.org/10.1371/journal.pone.0192586.t002
Table 3. Statistical significance tests (paired T-test) of the performance difference between the machine learning algorithms and the baselines on stroke case
identification.
Baseline Measure P Values between the Machine Learning Algorithms and the Baselines
LR SVM-P SVM-R RF ANN
ICD9 ACC 1.04E-12 1.63E-12 6.82E-13 1.65E-12 9.61E-12
P 4.99E-4 4.95E-6 7.01E-6 7.68E-9 4.67E-7
R 3.47E-13 1.40E-12 2.50E-13 9.98E-13 4.34E-12
F 1.50E-12 2.07E-12 8.01E-13 2.31E-12 9.13E-12
AUC 4.40E-11 3.46E-12 3.11E-12 8.43E-12 1.58E-11
AUC-PR 8.28E-12 1.25E-11 1.01E-11 2.46E-12 1.02E-11
CLIN ACC 1.63E-4 4.65E-5 1.16E-5 5.45E-5 6.96E-4
P 1.53E-7 6.62E-10 1.43E-10 1.04E-10 1.49E-10
R 0.999 1.00 0.999 1.00 1.00
F 1.00E-3 7.85E-4 1.13E-4 3.90E-3 1.48E-2
AUC 4.40E-11 1.50E-11 7.37E-12 1.23E-11 4.86E-11
AUC-PR 5.94E-9 3.25E-9 3.80E-9 3.94E-9 9.13E-9
indicates statistical significance (p value < 0.05).
https://doi.org/10.1371/journal.pone.0192586.t003
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Performance of stroke subtype detection
Table 4 shows the algorithm performance on stroke subtype detection, where the statistical sig-
nificance tests were reported in Table 5 on overall accuracy and per-class precision that were
of most interest to our study. The improvements of ML classifiers over ICD9 were statistically
significant. The ML classifiers also outperformed CLIN significantly on accuracy, and on pre-
cisions for ischemic stroke, TIA, and non-stroke “control”. The RF achieved the highest accu-
racy, and its improvements over the other classifiers were statistically significant (p value
<0.05 under paired t-test). Fig 6 illustrates the confusion matrices generated by ICD9, CLIN,
and the best-performing RF on the test set, in which an off-diagonal cell (i,j) numbers the
events in category i that were misclassified into category j. A more diagonal matrix suggests a
more accurate match between algorithm predictions and gold-standard labels.
Discussion
Despite being the most common approach for recording clinical conditions, the ICD-9 meth-
ods are sub-optimal for phenotyping diseases including stroke.[24] All ML algorithms per-
formed better than ICD9 significantly for stroke case detection. The RF achieved the best
performance in terms of the primary measure (Table 2). Its performance was also comparable
to that of trained research nurses (CLIN), with better tradeoff between precision and recall
(evidenced by the higher AUC-PRs achieved). Both ICD9 and CLIN did not achieve a preci-
sion of 95% (Fig 5), and thus their predictions could not be utilized directly to support genetic
and genomic research.[72, 73] In comparison, the best-performing RF could provide approxi-
mately 90% of the cases with 95% precision (dotted line in Fig 5), which would allow high sta-
tistical power for subsequent studies without labor-intensive clinician review.
For stroke subtype detection, the precisions obtained by the algorithms varied between sub-
types, with the best on hemorrhagic stroke, followed by ischemic stroke and TIA (Table 4).
The variation of performance was in accordance with complexities in diagnosing these stroke
subtypes: if a stroke is caused by hemorrhage, a CT scan can show evidence immediately.[40]
However, a normal CT scan does not rule out the diagnosis of ischemic stroke and a MRI,
Fig 5. Precision-recall curves generated by the algorithms.
https://doi.org/10.1371/journal.pone.0192586.g005
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particularly diffusion-weighted imaging, is typically required to confirm the findings.[41]
Finally, the MRI shows diagnostic findings in a low percentage of TIA cases.[39] Determining
TIA additionally relies on a patient’s ability to provide a history of transient stroke-like symp-
toms, and on a physician’s ability to match these symptoms to the operational concept of TIA.
Consequently, the clinical diagnosis of TIA is difficult and has limited inter-observer reliabil-
ity.[74]
The experimental results (Fig 6 and Table 4) suggested that such complexities in stroke
diagnosis affected the baselines and ML algorithms differently. Without comprehensive
information from patient records, the ICD9 baseline was unable to distinguish among stroke
subtypes accurately. The research nurses were capable of identifying hemorrhagic stroke,
but they tended to overcall more complicated subtypes (as evidenced by its confusion
matrix). Compared with humans, the confusion matrix made by RF showed fewer misclassi-
fications between ischemic stroke, TIA and non-stroke “control”. In fact, the RF showed
comparable performance on detecting hemorrhagic stroke and significantly better
Table 4. Performance of different classification algorithms for stroke type identification.
Category Measure Cross Validation Performance [%]
ICD9 CLIN LR SVM-P SVM-R RF ANN
Overall ACC 68.67 84.05 86.66 85.63 86.57 86.90 85.75
Ischemic Stroke P 80.64 83.36 89.37 93.87 92.22 92.58 90.31
R 79.59 97.57 94.17 88.48 91.05 90.53 91.80
F 80.11 89.91 91.70 91.08 91.62 91.54 91.04
Hemorrhagic Stroke P 87.40 93.88 94.31 94.68 93.85 92.69 94.61
R 82.80 98.85 96.97 94.36 96.24 97.98 94.51
F 84.99 96.27 95.60 94.50 95.00 95.23 94.50
Transient Ischemic Attack P 67.42 83.83 87.02 88.67 87.43 86.16 88.00
R 72.47 96.60 94.36 89.19 93.18 96.07 91.48
F 69.81 89.75 90.53 88.90 90.19 90.84 89.69
Non-stroke Control P 12.52 31.23 60.70 52.30 57.00 59.18 54.67
R 11.90 2.72 38.71 62.64 51.91 49.96 47.55
F 12.18 4.98 47.10 56.89 54.20 54.15 50.75
Category Measure Test Set Performance [%]
ICD9 CLIN LR SVM-P SVM-R RF ANN
Overall ACC 67.68 84.12 86.40 85.17 87.08 87.39 87.08
Ischemic Stroke P 79.50 82.43 89.91 94.58 93.28 93.60 91.16
R 79.69 97.00 92.07 86.06 90.02 89.66 91.71
F 79.59 89.12 90.97 90.12 91.62 91.59 91.43
Hemorrhagic Stroke P 88.02 97.18 97.14 95.98 95.53 94.48 94.35
R 84.48 98.85 97.70 95.98 98.28 98.28 95.98
F 86.22 98.01 97.42 95.98 96.88 96.34 95.16
Transient Ischemic Attack P 65.99 84.48 87.65 89.58 88.21 86.71 89.22
R 67.36 96.61 94.52 89.82 93.73 97.13 95.04
F 66.67 90.13 90.96 89.70 90.89 91.63 92.04
Non-stroke Control P 11.95 50.00 56.18 50.09 56.77 59.24 58.67
R 11.79 5.24 43.67 65.54 56.77 54.59 50.22
F 11.87 9.49 49.14 56.78 56.77 56.82 54.12
Bold numbers indicate the best results.
https://doi.org/10.1371/journal.pone.0192586.t004
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precisions on all other categories (Table 4). The findings suggested the strength of ML-based
methods in capturing and weighing information from different aspects of patient data to
detect stroke subtypes.
In addition, the feature selection process identified a subset of predictive variables that syn-
thesizes a human-oriented conceptualization of stroke diagnosis. The majority of the variables
were related to diagnostic tests for stroke (CT/MRI, ANG and CU in Fig 4), and patients’ phys-
iological characteristics during hospitalization (SS and ED).[75] Interventions (IT) such as
carotid endarterectomies were used for stroke prevention and they could imply higher risk of
stroke onset. Finally, patients’ demographics (DEMO) and substance use behaviors (SU) were
shown to be influential, which were consistent with the literature findings.[6, 11, 20] In partic-
ular, the CT/MRI and SS were the most predictive variables and they yielded more than 98%
of the performance gain (Fig 4). The relative importance of these variables could help physi-
cians weigh the information when chart reviewing a patient’s record.
Our findings contribute to the body of knowledge in stroke research on several fronts. In
the experiments the ML models were evaluated on a population from multiple hospitals, and
the positive results suggested their generalizability in stroke detection. As such, the developed
approach has potential to facilitate case identification for multi-site genomic studies.[72, 73]
By leveraging a centralized dataset, a coordinating center could develop and disseminate ML
models along with data abstraction protocols. The participating sites could then abstract site-
specific data and apply the models to identify stroke cases. The feature selection uncovered a
subset of predictive variables (CT/MRI and SS) that could facilitate the development of more
effective phenotyping algorithms to reduce workload in data abstraction, which is an interest-
ing direction of our future work. In addition, the ML approach has potential to generalize to
other applications in stroke research. Currently, stroke epidemiology studies that utilize
administrative databases suffer from misclassification bias by using only ICD discharge codes,
whereas the studies involving manual inspection such as the GCNKSS are hindered by time
required for data collection and adjudication. By calibrating the ML predictions with linear
regression, we could estimate incidence rates of stroke in a study region with a high degree of
confidence.[76] As such, the developed approach could provide great benefit for reducing
time and effort for executing stroke-related epidemiology studies, allowing near real-time esti-
mates of stroke incidence.
Table 5. Statistical significance tests (paired T-test) of the performance difference between the machine learning algorithms and the baselines on stroke type
identification.
Baseline Measure P Values between the ML Algorithms and the Baselines
LR SVM-P SVM-R RF ANN
ICD9 Overall ACC 2.23E-10 2.62E-10 1.63E-9 1.65E-10 3.21E-10
P (Ischemic stroke) 6.07E-9 9.81E-8 5.24E-8 1.02E-8 4.40E-8
P (Hemorrhagic stroke) 1.15E-5 4.73E-5 2.27E-5 4.87E-5 7.92E-5
P (TIA) 2.13E-10 2.17E-9 7.82E-11 3.72E-10 8.84E-11
P (Non-stroke control) 2.63E-9 8.46E-9 1.61E-8 8.88E-10 2.19E-9
CLIN Overall ACC 2.40E-3 1.89E-2 1.64E-4 7.57E-7 2.60E-3
P (Ischemic stroke) 4.35E-11 3.64E-9 3.94E-9 1.73E-10 5.33E-9
P (Hemorrhagic stroke) 0.104 0.229 0.529 0.993 0.116
P (TIA) 3.33E-5 6.05E-5 4.56E-6 2.34E-5 1.33E-4
P (Non-stroke control) 1.90E-3 2.90E-3 7.05E-4 3.14E-4 2.00E-3
indicates statistical significance (p value < 0.05).
https://doi.org/10.1371/journal.pone.0192586.t005
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Fig 6. Confusion matrices generated by ICD9, CLIN, and RF on the test set.
https://doi.org/10.1371/journal.pone.0192586.g006
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Error analysis, limitations and future work
We performed error analysis for the RF algorithm on stroke subtype detection. The algorithm
made 204 errors on the test data. By reviewing physicians’ clarification on these events, we
grouped the errors into nine categories. Table 6 shows the error categories and the numbers of
misclassifications between gold-standard and predicted labels for each category. Approxi-
mately 42% of errors were due to missing information in the data (categories 1–4). For some
events the CT/MRI tests were not performed, possibly due to that the patients did not have
stroke symptoms and hence the tests were determined unnecessary by healthcare providers
(category 1). The observation suggested that interaction between variables (e.g., no symptoms
plus no diagnostic tests) could be informative for stroke diagnosis. In the future we will explic-
itly model variable connections with tensor product representation and see if it improves the
accuracy in stroke detection.[77] In addition, some findings were stored in textual data fields
and not used in the current study (category 2). Utilizing NLP algorithms to extract informa-
tion from these fields is therefore another direction of our future work. Finally, important
information was missed occasionally due to healthcare settings (e.g., outpatient) and difficulty
of abstraction (e.g., missing subtle information from clinical notes) (categories 3–4). This
observation could benefit the design of a more effective abstraction protocol, which however,
is out of scope of this study.
Another 32% of errors were ascribed to the complexity of events (categories 5–8). The algo-
rithm identified physicians’ decisions well but did not capture more rigid inclusion criteria,
hence misclassifying a noticeable amount of non-stroke “controls” into cases (category 5). It
also confused between ischemic and hemorrhagic strokes when the events were ischemic
strokes with hemorrhagic conversion (category 6). To solve these problems, we plan to imple-
ment knowledge-based post-processing to explicitly include structured inclusions and to
adjust algorithm predictions when patients present both ischemic and hemorrhagic character-
istics. In addition, the algorithm misclassified several ischemic events with unknown etiology,
in which the patients did not present traditional stroke symptoms and diagnostic findings (cat-
egory 7). Understanding the etiology of these events will help identify predictors for the ML-
based methods, which warrants further investigation by neurologists.
Finally, approximately 21% of errors were caused by conflicts between patients’ symptoms
and diagnostic findings (mainly CT/MRI findings). If a patient had focal stroke symptoms
but CT/MRI findings were normal, the study physicians often override the findings and
Table 6. Misclassification errors made by the RF algorithm on the test set.
ID Gold-standard label IS HS TIA NS
Predicted label HS TIA NS NS IS NS IS HS TIA
1 No focal symptoms and key diagnostic tests (CT/MRI findings) were not performed (16.67%) 0 0 2 0 0 0 12 0 20
2 Missing CT/MRI findings (e.g., “no acute intracranial abnormality”) stored in textual data fields (11.27%) 0 0 6 1 0 1 1 0 14
3 Physicians used information not in the data (e.g., raw MRI images and clinical notes) to make the decisions (6.86%) 0 0 7 0 1 1 3 1 1
4 Missing information (e.g., MRI findings) due to ED or outpatient settings (6.86%) 0 1 4 1 0 2 2 0 4
5 Dilemma samples. Physicians determined as cases but the patients did not meet all inclusion criteria. The events
were labeled as non-stroke “control” in our study (14.71%)
0 0 0 0 0 0 27 2 1
6 Complex cases. Ischemic stroke with hemorrhagic conversion (4.90%) 7 0 3 0 0 0 0 0 0
7 Undetermined etiology of cases. No focal symptoms or findings from diagnostic tests (12.25%) 0 4 16 1 0 4 0 0 0
8 Conflict findings between symptoms and diagnostic tests (21.08%) 0 0 33 0 1 1 4 0 4
9 Wrong predictions. Unidentified reason (5.39%) 0 0 2 0 0 0 1 0 8
IS: Ischemic stroke; HS: Hemorrhagic stroke; TIA: Transient ischemic attack; NS: non-stroke control. Percentage of errors for each category is presented in the bracket.
https://doi.org/10.1371/journal.pone.0192586.t006
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considered the patient a case because the symptoms could be mild such that they did not show
up on CT/MRI. In contrast, if there were multiple CT/MRI tests showing consistent findings,
the physicians would weigh more on diagnostic results even if the patient did not have symp-
toms. Compared with stroke physicians, the RF algorithm always weighted more on CT/MRI
findings and had less flexibility in balancing conflict variables, consequently misclassifying a
notable amount of events in which the CT/MRI findings were normal. To alleviate this prob-
lem, we will develop advanced multi-layer classifiers in our future work to balance weights
between different variable sets before aggregating them for stroke detection.[47]
One significant limitation of the study is that the variables used were abstracted by research
nurses. Manual abstraction of clinical variables requires not only substantial subspecialty
expertise, but also intensive manpower. Consequently, the limitation could hinder the dissemi-
nation of the developed approach across institutions. To alleviate this problem, variables
should ideally be extracted from EHR data automatically. Recent studies have shown the feasi-
bility of automating abstraction of stroke related risk factors from EHR data.[78, 79] Because
the ML models could achieve competitive performance with a limited set of 44 variables (CT/
MRI and SS), we anticipate that automated data abstraction for stroke detection is feasible
with appropriate NLP and regular expression algorithms.
Another limitation is that we did not assess the inter-observer reliabilities among stroke
physicians in the epidemiology study. Although each hospitalization event was reviewed by at
least one clinical nurse and a stroke physician, and the complex events were adjudicated
through group discussion, variability may exist in the final adjudications, particularly for TIA
and stroke cases with negative diffusion-weighted imaging results. To address this limitation,
we have initiated documentation of physician decisions in the ongoing GCNKSS, which allows
for the evaluation of inter-observer reliabilities on future data. In addition, we grouped the
stroke subtypes into four categories to avoid the problem of data sparseness. To improve the
granularity of detection, we will continue collecting data from the GCNKSS to develop more
powerful predictive models.
As a final limitation, the work was limited to reporting system performance on a population
collected in a single epidemiology study. To assess its generalizability, project planning is in
progress to evaluate the developed approach in a separate stroke population with different data
collection and representation methods.
Conclusions
In this study we demonstrated the strength of ML technologies in identifying stroke cases and
pathological subtypes. By analyzing a broad array of patient data, the ML models showed good
capacity for detecting stroke diagnosis. The algorithms significantly outperformed the ICD-9
method that is commonly implemented in current studies. Their performance was comparable
to that of trained research nurses, with better tradeoff between precision and recall. The feature
selection uncovered a subset of predictive variables, which could facilitate future development
of effective stroke phenotyping algorithms. The anticipated benefits of machine learning have
potential to bring stroke phenotyping to the forefront of biomedical research, unlocking high
statistical power for subsequent genetic and genomic studies.
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